Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A10196 | Pages: NA | Charts: NA | Tables: NA |
Creatinine is integrated into humans around the time of muscle contractions. The kidney glomerulus detaches the creatinine substance from the blood and is passed on to the urine. Creatinine test engaged for the measurement of the glomerular filtration rate in the kidney. Therefore, the creatinine test is widely utilized to evaluate the kidney functioning. Currently, if we have a look at the market, automation-ready and direct procedures are acquiring the popularity in the R & D activities along with the drug discovery for creatinine measurement concentration.
Creatinine measurement tests are carried out for the analysis of the kidney functioning. These tests give information about chronic kidney disease levels and the risks of renal failures. Additionally, creatinine level increase in the blood can happen due to kidney obstruction, rise in the consumption of proteins, dehydration, and increase consumption of medications.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.
Owing to such factors, COVID 19 is expected to have a significant impact on the Creatinine Measurement market.
The increasing frequency of the renal disorders along with the increasing demand for creatinine measurement reagents and kits is supplemented due to the increasing occurrences of chronic disorders that are impacting the function of the kidney are the major drivers of the creatinine market. The increasing population observed along with the increasing cases of renal disorders, government policies that are supporting in the promotion of renal health, and the arrival of new technologies are the major factors boosting the creatinine measurement market.
On the other hand, the preferences of healthcare professionals are shifting towards novel techniques, which comprises the identification of renal dysfunction biomarkers, along with the lack of auguring value that is
hampering the growth of the creatinine measurement market.
On June 01, 2020 Akcea got an approval for the compensation of TEGSEDI in Portugal for hereditary transthyretin amyloidosis treatment along with polyneuropathy TEGSEDI is the pioneer antisense oligonucleotide medicine was made available to the patients in Portugal.
On May 13, 2020, Amgen introduced their Oncology Pipeline at ASCO 2020 which showed updates of the Data Evaluating Sotorasib which is an Investigational KRASG12C Inhibitor.
Hospitals and diagnostic laboratories are the major end-users for the creatinine measurement market. Among them, hospitals are the biggest end-users due to their established infrastructures and advances in the diagnostic assembly for better results in the diagnosis of shorter periods. Diagnostic laboratories are also growing due to various market players are signing collaborations which is helping improve their influence on the creatinine measurement market.
Key benefits of the report:
Questions answered in the Creatinine Measurement Market research report:
Key Market Segments
Key Market Players
